Elanco Animal Health
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Elanco Animal Health generated cash of $271,000,000, which is less than the previous year. Cash used in financing activities reached the amount of -$83,000,000 last year. Net change in cash is therefore $7,000,000.
Cash Flow
| 2015 | 6.6M | -4.99B | 5.35B |
|---|---|---|---|
| 2016 | 155.9M | -182.1M | -149.6M |
| 2017 | 173.8M | -964.6M | 847.5M |
| 2018 | 487.3M | -127M | -35.2M |
| 2019 | 224.1M | -234.8M | -304.8M |
| 2020 | -41M | -4.77B | 4.95B |
| 2021 | 483M | -530M | 210M |
| 2022 | 452M | -179M | -549M |
| 2023 | 271M | -169M | -83M |
ELAT Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 0 | 638M | 506M | 345.1M | 677.5M | 323.4M | 258.8M | 460.6M | 116M |
Operating activities | |||||||||
Net income | -1.23B | -78M | -472M | -560.1M | 67.9M | 86.5M | -310.7M | -47.9M | -210.8M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 694M | 682M | 716M | 516.9M | 314.5M | 296M | 318.4M | 254.4M | 236.9M |
Stock-based compensation expense | 46M | 59M | 66M | 47.7M | 49.4M | 26M | 25M | 20.4M | 13.4M |
| Deferred income tax benefit | 46M | 59M | 66M | 47.7M | 49.4M | 26M | 25M | 20.4M | 13.4M |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -40M | 14M | -25M | 14M | -172.4M | -122M | 48.4M | -80.7M | -94.6M |
Inventories | -160M | -269M | 27M | -94.7M | -33.1M | -20.1M | -39M | -89.1M | 14.9M |
Accounts payable | -94M | -98M | -120M | 369.3M | -29.2M | 116.1M | -8.4M | 37.1M | 116.4M |
Cash generated by operating activities | 271M | 452M | 483M | -41M | 224.1M | 487.3M | 173.8M | 155.9M | 6.6M |
Investing activities | |||||||||
Purchases Of Investments | 0 | 0 | 0 | 176.3M | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -140M | -184M | -197M | -310.9M | -197.4M | -134.5M | -98.6M | -110.3M | -100.1M |
Acquisitions Net | -19M | 13M | -342M | -4.56B | -32.8M | 0 | -882.1M | -45M | -5.28B |
Cash generated by investing activities | -169M | -179M | -530M | -4.77B | -234.8M | -127M | -964.6M | -182.1M | -4.99B |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | 0 | 1.21B | 0 | 1.65B | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -823M | -951.5M | 0 | -7.5M | 0 | 0 | 0 |
Cash used in financing activities | -83M | -549M | 210M | 4.95B | -304.8M | -35.2M | 847.5M | -149.6M | 5.35B |
Net Change In Cash | 7M | -293M | 132M | 160.3M | -332.4M | 354.1M | 64.6M | -201.8M | 344.6M |
Cash at end of period | 7M | 345M | 638M | 505.4M | 345.1M | 677.5M | 323.4M | 258.8M | 460.6M |
| Data source | Data source | Data source | Data source | Data source | Data source |